1. Registration Registration
form fees
Doctors, scientists, lecturers, etc. RM500
1st National
Name: …………………………………………………
Post-graduate students RM450 Stem Cell
…………………………………………………………
Organisation: ...………………………………………. Congress
Address: …...………………………………………….
…………………………………………………………. ‘Delivering the
promise of cell
………………………………………………………….
therapies’
Telephone (O):…………………………………………
Telephone (HP)………………………………………
Email: …………………………………………………..
I would like to register for: (Please tick)
Stem cell congress
Doctors, scientists, lecturers
Post-graduate student
secretariat 29-30th October 2012
I am submitting an abstract. Istana Hotel, Kuala Lumpur
UKM Medical Molecular Biology Institute
Payment: 7th Floor, Clinical Block,
Cheque/bank draft made payable to UKM Medical Centre
BENDAHARI UKM for RM………….. Jalan Yaacob Latiff, Bandar Tun Razak
Organised by:
Cash Cheras, 56000 Kuala Lumpur, MALAYSIA
Ministry of Health, Malaysia
Local order no:……………………….
Phone: 603-91717162 UKM Medical Molecular Biology Institute
Fax: 603-91717185
Please send completed form and payment to:
Email: umbievent@ppukm.ukm.edu.my
1st National Stem Cell Congress Website: http://www.ukm.my/umbi
UKM Medical Molecular Biology Institute
7th Floor, Clinical Block,
UKM Medical Centre
Jalan Yaacob Latiff, Bandar Tun Razak
Cheras, 56000 Kuala Lumpur, MALAYSIA

2. SCIENTIFIC POSTER PRESENTATIONS
Welcome Scientific We would like to invite researchers and scientists to
message programme submit their research for the poster presentations. The
instructions are as follows:
PLENARY LECTURES All abstracts must be submitted by 15th
There has been a tremendous surge in stem cell
October 2012.
research over the past decade resulting in many Bringing cell therapy from lab to bedside
All abstracts are to be written in English
new findings in the aspects of stem cell biology Harnessing stem cells to understand The abstract must not contain more than 300 words
and also the various applications. Although the diseases and finding cures in a single paragraph.
area of stem cell is still relatively new in Malaysia, The author’ last names, initials, their institutions, city
Biology of neural stem cells and country should be listed immediately beneath the
there is already a good number of local abstract title, typed in upper and lower case and
Cell-based therapies: The business
researchers involved. There is also a growing single-spaced.
number of companies dealing with stem cell perspective The abstract should be typeset in upper and lower
banking as well as therapies. The regulatory pro- Biology of cancer vaccines case and single-spaced. The format of writing out
the: Aims, Materials & Methods, Results, Conclusion
cesses are coordinated through the various ethic is greatly recommended.
committees and the Ministry of Health plays a SYMPOSIA No abstract that has been presented orally or as a
lead role in terms of regulating both research poster at a previous national or international meeting
Clinical applications of this any society will be considered for presentation
and therapies.
Mesenchymal stem cells for Type I at this meeting.
diabetes mellitus and liver disorders Abstracts must be submitted either in the form of a
The decision to hold the first stem cell congress Microsoft Word file (document file) using Arial font.
Corneal disorders Abstracts must be saved and send directly to the
in Malaysia is timely. This will be an opportunity
Neurological disorders Congress Secretariat via email to
for the local scientists and researchers to refresh umbievent@ppukm.ukm.edu.my
and consolidate their knowledge in this exciting Regulatory issues
area as well as interacting with the impressive GMP and GTP compliance
array of speakers whom we have invited. Restrictive or permissive: Which way
to go?
The organizing committee would like to invite Biology to applications
you to participate this congress. We hope to see Dendritic cell vaccines for cancers
you in Kuala Lumpur.
Stem cells for orthopaedic disorders
Designing clinical trials
PROFESSOR DATUK DR. A RAHMAN A JAMAL
CHAIRMAN
PLENARY DISCUSSION
ORGANISING COMMITTEE
Technological, safety, ethical, commercial and
reimbursement issues